Dewetting transition assisted clearance of (NFGAILS) amyloid fibrils from cell membranes by graphene

Journal of Chemical Physics

Volumn 141, Issue 22, 2014, Pages

  Liu, Jiajia ^a   Yang, Zaixing ^a   Li, Haotian ^b   Gu, Zonglin ^a   Antonio Garate, Jose ^c   Zhou, Ruhong ^a,c,d  

^a SOOCHOW UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; CYTOLOGY; GLYCOPROTEINS; HYDROPHOBICITY; MEDICAL NANOTECHNOLOGY; MEMBRANES; MOLECULAR DYNAMICS; NANOSHEETS; PROTEINS; SURFACE CHEMISTRY;

CELL MEMBRANE SURFACE; COMPETITIVE ADSORPTION; CONFORMATIONAL DISEASE; DEWETTING TRANSITION; HYDROPHOBIC SURFACES; MOLECULAR DYNAMICS SIMULATIONS; PHOSPHOLIPIDIC MEMBRANES; TYPE II DIABETES MELLITUS;

GRAPHENE;

AMYLIN; AMYLOID; GRAPHITE; NANOMATERIAL;

ADSORPTION; CELL MEMBRANE; CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DYNAMICS; WETTABILITY;

ADSORPTION; AMYLOID; CELL MEMBRANE; GRAPHITE; HUMANS; ISLET AMYLOID POLYPEPTIDE; MOLECULAR DYNAMICS SIMULATION; NANOSTRUCTURES; WETTABILITY;

EID: 84922534730     PISSN: 00219606     EISSN: 10897690     Source Type: Journal    
DOI: 10.1063/1.4901113     Document Type: Article

References (83)

1. J. D. Harper and P. T. Lansbury, "Models of amyloid seeding in Alzheimier's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins," Annu. Rev. Biochem. 66, 385-407 (1997).
2. C. M. Dobson, "Protein folding and misfolding," Nature (London) 426(6968), 884-890 (2003).
3. N. Gregersen, P. Bross, S. Vang, and J. H. Christensen, "Protein misfolding and human disease," Annu. Rev. Genom. Hum. Genet. 7, 103-124 (2006).
4. J. Lee, E. K. Culyba, E. T. Powers, and J. W. Kelly, "Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers," Nat. Chem. Biol. 7(9), 602-609 (2011).
5. P. Westermark, C. Wernstedt, T. O'Brien, D. Hayden, and K. Johnson, "Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone," Am. J. Pathol. 127(3), 414-417 (1987), available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899776/.
6. J. W. M. Hoppener, B. Ahren, and C. J. M. Lips, "Islet amyloid and type 2 diabetes mellitus," N. Engl. J. Med. 343(6), 411-419 (2000).
7. M. P. Lambert, A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed et al., "Diffusible, nonfibrillar ligands derived from ab1-42 are potent central nervous system neurotoxins," Proc. Natl. Acad. Sci. U.S.A. 95(11), 6448-6453 (1998).
8. J. Hardy and D. J. Selkoe, "The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics," Sci. Aging Knowl. Environ. 2002(29), 353-356 (2002).
9. P. Tremblay, Z. Meiner, M. Galou, C. Heinrich, C. Petromilli et al., "Doxycycline control of prion protein transgene expression modulates prion disease in mice," Proc. Natl. Acad. Sci. U.S.A. 95(21), 12580-12585 (1998).
10. L. Khemtemourian, J. A. Killian, J. W. M. Hoppener, and M. F. M. Engel, "Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus," Exp. Diabetes Res. 2008(9), 421287-1.
11. M. T. Pastor, N. Kummerer, V. Schubert, A. Esteras-Chopo, C. G. Dotti et al., "Amyloid toxicity is independent of polypeptide sequence, length and chirality," J. Mol. Biol. 375(3), 695-707 (2008).
12. M. F. M. Engel, "Membrane permeabilization by islet amyloid polypeptide,"Chem. Phys. Lipids 160(1), 1-10 (2009).
13. N. B. Last, E. Rhoades, and A. D. Miranker, "Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity," Proc. Natl. Acad. Sci. U.S.A. 108(23), 9460-9465 (2011).
14. J. Janson, R. H. Ashley, D. Harrison, S. McIntyre, and P. C. Butler, "The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles," Diabetes 48(3), 491-498 (1999).
15. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli et al., "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases," Nature (London) 416(6880), 507-511 (2002).
16. E. Sparr, M. F. M. Engel, D. V. Sakharov, M. Sprong, J. Jacobs et al., "Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers," FEBS Lett. 577(1-2), 117-120 (2004).
17. M. F. M. Engel, L. Khemtemourian, C. C. Kleijer, H. J. D. Meeldijk, J. Jacobs et al., "Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane," Proc. Natl. Acad. Sci. U.S.A. 105(16), 6033-6038 (2008).
18. A. Laganowsky, C. Liu, M. R. Sawaya, J. P. Whitelegge, J. Park et al., "Atomic view of a toxic amyloid small oligomer," Science 335(6073), 1228-1231 (2012).
19. M. Wogulis, S. Wright, D. Cunningham, T. Chilcote, K. Powell et al., "Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death," J. Neurosci. 25(5), 1071-1080 (2005).
20. H. Jang, L. Connelly, F. T. Arce, S. Ramachandran, B. L. Kagan et al., "Mechanisms for the insertion of toxic, fibril-like beta-amyloid oligomers into the membrane," J. Chem. Theory Comput. 9(1), 822-833 (2013).
21. R. Lal, A. Quist, L. Doudevski, H. Lin, R. Azimova et al., "Amyloid ion channels: A common structural link for protein-misfolding disease," Proc. Natl. Acad. Sci. U.S.A. 102(30), 10427-10432 (2005).
22. T. A. Mirzabekov, M. C. Lin, and B. L. Kagan, "Pore formation by the cytotoxic islet amyloid peptide amylin," J. Biol. Chem. 271(4), 1988-1992 (1996).
23. R. Kayed, Y. Sokolov, B. Edmonds, T. M. McIntire, S. C. Milton et al., "Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases," J. Biol. Chem. 279(45), 46363-46366 (2004).
24. Z. Chang, Y. Luo, Y. Zhang, and G. Wei, "Interactions of a beta 25-35 beta-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: An all-atom molecular dynamics study," J. Phys. Chem. B 115(5), 1165-1174 (2011).
25. J. Zhao, Y. Luo, H. Jang, X. Yu, G. Wei et al., "Probing ion channel activity of human islet amyloid polypeptide (amylin)," Biochim. Biophys. Acta 1818(12), 3121-3130 (2012).
26. Y. Zhang, Y. Luo, Y. Deng, Y. Mu, and G. Wei, "Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations," Plos One 7(5), e38191 (2012).
27. C. H. Davis and M. L. Berkowitz, "Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: A molecular dynamics study," Biophys. J. 96(3), 785-797 (2009).
28. E. Drolle, F. Hane, B. Lee, and Z. Leonenko, "Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in alzheimer's disease," Drug Metabol. Rev. 46(2), 207-223 (2014).
29. H. Jang, F. T. Arce, S. Ramachandran, R. Capone, R. Lal et al., "Beta-barrel topology of alzheimer's beta-amyloid ion channels," J. Mol. Biol. 404(5), 917-934 (2010).
30. K. A. Burke, E. A. Yates, and J. Legleiter, "Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration," Front. Neurol. 4, 17 (2013).
31. D. Morshedi, N. Rezaei-Ghaleh, A. Ebrahim-Habibi, S. Ahmadian, and M. Nemat-Gorgani, "Inhibition of amyloid fibrillation of lysozyme by indole derivatives - possible mechanism of action," FEBS J 274(24), 6415-6425 (2007).
32. D. Howlett, P. Cutler, S. Heales, and P. Camilleri, "Hemin and related porphyrins inhibit b-amyloid aggregation," FEBS Lett. 417(2), 249-251 (1997).
33. C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, S. Lindman, A. M. Minogue et al., "Inhibition of amyloid-b protein fibrillation by polymeric nanoparticles," J. Am. Chem. Soc. 130(46), 15437-15443 (2008).
34. A. Frydman-Marom, M. Rechter, I. Shefler, Y. Bram, D. E. Shalev et al., "Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies," Angew. Chem., Int. Ed. 48(11), 1981-1986 (2009).
35. F. C. Bronfman, J. Garrido, A. Alvarez, C. Morgan, and N. C. Inestrosa, "Laminin inhibits amyloid-b-peptide fibrillation," Neurosci. Lett. 218(3), 201-203 (1996).
36. K. J. Barnham, V. B. Kenche, G. D. Ciccotosto, D. P. Smith, D. J. Tew et al., "Platinum-based inhibitors of amyloid-b as therapeutic agents for Alzheimer's disease," Proc. Natl. Acad. Sci. U.S.A. 105(19), 6813-6818 (2008).
37. Z. Liu, J. T. Robinson, X. M. Sun, and H. J. Dai, "Pegylated nanographene oxide for delivery of water-insoluble cancer drugs," J. Am. Chem. Soc. 130(33), 10876-10877 (2008).
38. V. C. Sanchez, A. Jachak, R. H. Hurt, and A. B. Kane, "Biological interactions of graphene-family nanomaterials: An interdisciplinary review,"Chem. Res. Toxicol. 25(1), 15-34 (2012).
39. L. Feng and Z. Liu, "Graphene in biomedicine: Opportunities and challenges,"Nanomedicine 6(2), 317-324 (2011).
40. W. Hu, C. Peng, W. Luo, M. Lv, X. Li et al., "Graphene-based antibacterial paper," ACS Nano 4(7), 4317-4323 (2010).
41. O. Akhavan and E. Ghaderi, "Toxicity of graphene and graphene oxide nanowalls against bacteria," ACS Nano 4(10), 5731-5736 (2010).
42. S. Liu, T. H. Zeng, M. Hofmann, E. Burcombe, J. Wei et al., "Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: Membrane and oxidative stress," ACS Nano 5(9), 6971-6980 (2011).
43. K. Krishnamoorthy, M. Veerapandian, L. H. Zhang, K. Yun, and S. J. Kim, "Antibacterial efficiency of graphene nanosheets against pathogenic bacteria via lipid peroxidation," J. Phys. Chem. C 116(32), 17280-17287 (2012).
44. Y. Tu, M. Lv, P. Xiu, T. Huynh, M. Zhang et al., "Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets,"Nat. Nanotechnol. 8(8), 594-601 (2013).
45. M. Mahmoudi, O. Akhavan, M. Ghavami, F. Rezaee, and S. M. A. Ghiasi, "Graphene oxide strongly inhibits amyloid-b fibrillation," Nanoscale 4(23), 7322-7325 (2012).
46. 33-42 peptide assembly by graphene oxide," Chem. Eur. J. 20, 1-6 (2014).
47. N. Todorova, A. J. Makarucha, N. D. M. Hine, A. A. Mostofi, and I. Yarovsky, "Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: Multiscale theoretical simulations,"Plos Comput. Biol. 9(12), e1003360 (2013).
48. 22-28 peptide by molecular dynamics simulation," PloS One 8(6), e65579 (2013).
49. C. X. Li, J. Adamcik, and R. Mezzenga, "Biodegradable nanocomposites of amyloid fibrils and graphene with shape-memory and enzyme-sensing properties," Nat. Nanotechnol. 7(7), 421-427 (2012).
50. M. Li, X. J. Yang, J. S. Ren, K. G. Qu, and X. G. Qu, Using graphene oxide high near-infrared absorbance for photothermal treatment of alzheimer's disease," Adv. Mater. 24(13), 1722-1728 (2012).
51. J. T. Nielsen, M. Bjerring, M. D. Jeppesen, R. O. Pedersen, J. M. Pedersen et al., "Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy," Angew. Chem.-Int. Ed. 48(12), 2118-2121 (2009).
52. W. Humphrey, A. Dalke, and K. Schulten, "VMD: Visual molecular dynamics,"J. Mol. Graph. 14(1), 33 (1996).
53. E. Lindahl, B. Hess, and D. van derSpoel, "Gromacs 3.0: A package for molecular simulation and trajectory analysis," J. Mol. Model. 7(8), 306-317 (2001).
54. N. Choudhury and B. M. Pettitt, "On the mechanism of hydrophobic association of nanoscopic solutes," J. Am. Chem. Soc. 127(10), 3556-3567 (2005).
55. O. Berger, O. Edholm, and F. Jahnig, "Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature," Biophys. J. 72(5), 2002-2013 (1997).
56. D. P. Tieleman, J. L. MacCallum, W. L. Ash, C. Kandt, Z. T. Xu et al., "Membrane protein simulations with a united-atom lipid and all-atom protein model: Lipid-protein interactions, side chain transfer free energies and model proteins," J. Phys.-Condens. Matter 18(28), S1221-S1234 (2006).
57. P. Bjelkmar, P. S. Niemela, I. Vattulainen, and E. Lindahl, "Conformational changes and slow dynamics through microsecond polarized atomistic molecular simulation of an integral Kv1.2 ion channel," PLoS Comput. Biol. 5(2), 14 (2009).
58. G. Bussi, D. Donadio, and M. Parrinello, "Canonical sampling through velocity rescaling," J. Chem. Phys. 126(1), 7 (2007).
59. M. Parrinello and A. Rahman, "Polymorphic transitions in single-crystals - a new molecular-dynamics method," J. Appl. Phys. 52( 12), 7182-7190 (1981).
60. D. J. Selkoe, "Alzheimer's disease: Genes, proteins, and therapy," Physiol. Rev. 81(2), 741-766 (2001).
61. B. Hess, H. Bekker, H. J. C. Berendsen, and J. Fraaije, "Lincs: A linear constraint solver for molecular simulations," J. Comput. Chem. 18(12), 1463-1472 (1997).
62. S. Miyamoto and P. A. Kollman, "Settle - an analytical version of the shake and rattle algorithm for rigid water models," J. Comput. Chem. 13(8), 952-962 (1992).
63. L. Hua, X. Huang, P. Liu, R. Zhou, and B. J. Berne,"Nanoscale dewetting transition in protein complex folding," J. Phys. Chem. B 111(30), 9069-9077 (2007).
64. P. Liu, X. Huang, R. Zhou, and B. J. Berne, "Observation of a dewetting transition in the collapse of the melittin tetramer," Nature (London) 437(7055), 159-162 (2005).
65. Z. Yang, B. Shi, H. Lu, P. Xiu, and R. Zhou, "Dewetting transitions in the self-assembly of two amyloidogenic beta-sheets and the importance of matching surfaces," J. Phys. Chem. B 115(38), 11137-11144 (2011).
66. N. Giovambattista, C. F. Lopez, P. J. Rossky, and P. G. Debenedetti, "Hydrophobicity of protein surfaces: Separating geometry from chemistry,"Proc. Natl. Acad. Sci. U.S.A. 105(7), 2274-2279 (2008).
67. R. Zhou, X. Huang, C. J. Margulis, and B. J. Berne, "Hydrophobic collapse in multidomain protein folding," Science 305(5690), 1605-1609 (2004).
68. R. Abel, L. Wang, R. A. Friesner, and B. J. Berne, "A displaced-solvent functional analysis of model hydrophobic enclosures," J. Chem. Theory Comput. 6(9), 2924-2934 (2010).
69. R. Abel, T. Young, R. Farid, B. J. Berne, and R. A. Friesner, "Role of the active-site solvent in the thermodynamics of factor xa ligand binding," J. Am. Chem. Soc. 130(9), 2817-2831 (2008).
70. T. Young, R. Abel, B. Kim, B. J. Berne, and R. A. Friesner, "Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding," Proc. Natl. Acad. Sci. U.S.A. 104(3), 808-813 (2007).
71. T. Young, L. Hua, X. Huang, R. Abel, R. Friesner et al., "Dewetting transitions in protein cavities," Proteins 78(8), 1856-1869 (2010).
72. F. Zhu and G. Hummer, "Pore opening and closing of a pentameric ligandgated ion channel," Proc. Natl. Acad. Sci. U.S.A. 107(46), 19814-19819 (2010).
73. G. Zuo, X. Zhou, Q. Huang, H. Fang, and R. Zhou, "Adsorption of villin headpiece onto graphene, carbon nanotube, and C60: Effect of contacting surface curvatures on binding affinity," J. Phys. Chem. C 115, 23323-23328 (2011).
74. 22 on matrix metalloproteinase-2: Molecular insight into drug-like nanomedicine," Sci. Rep. 4, 4775 (2014).
75. S. Q. Wang, E. S. Humphreys, S. Y. Chung, D. F. Delduco, S. R. Lustig et al., "Peptides with selective affinity for carbon nanotubes," Nat. Mater. 2(3), 196-200 (2003).
76. V. Zorbas, A. L. Smith, H. Xie, A. Ortiz-Acevedo, A. B. Dalton et al., "Importance of aromatic content for peptide/single-walled carbon nanotube interactions," J. Am. Chem. Soc. 127(35), 12323-12328 (2005).
77. X. J. Li, W. Chen, Q. W. Zhan, L. M. Dai, L. Sowards et al., "Direct measurements of interactions between polypeptides and carbon nanotubes," J. Phys. Chem. B 110(25), 12621-12625 (2006).
78. C. G. Salzmann, M. A. H. Ward, R. M. J. Jacobs, G. Tobias, and M. L. H. Green, "Interaction of tyrosine-, tryptophan-, and lysine-containing polypeptides with single-wall carbon nanotubes and its relevance for the rational design of dispersing agents," J. Phys. Chem. C 111(50), 18520-18524 (2007).
79. Z. Su, K. Mui, E. Daub, T. Leung, and J. Honek, "Single-walled carbon nanotube binding peptides: Probing tryptophan's importance by unnatural amino acid substitution," J. Phys. Chem. B 111(51), 14411-14417 (2007).
80. H. Xie, E. J. Becraft, R. H. Baughman, A. B. Dalton, and G. R. Dieckmann, "Ranking the affinity of aromatic residues for carbon nanotubes by using designed surfactant peptides," J. Pept. Sci. 14(2), 139-151 (2008).
81. Z. X. Yang, Z. G. Wang, X. L. Tian, P. Xiu, and R. H. Zhou, "Amino acid analogues bind to carbon nanotube via pi-pi interactions: Comparison of molecular mechanical and quantum mechanical calculations," J. Chem. Phys. 136(2), 025103 (2012).
82. T. Serizawa, Z. H. Gao, C. Y. Zhi, Y. Bando, and D. Golberg, "Isolation of individual boron nitride nanotubes via peptide wrapping," J. Am. Chem. Soc. 132(14), 4976-4977 (2010).
83. C. C. Ge, J. F. Du, L. N. Zhao, L. M. Wang, Y. Liu et al., "Binding of blood proteins to carbon nanotubes reduces cytotoxicity," Proc. Natl. Acad. Sci. U.S.A. 108(41), 16968-16973 (2011).